Fund Holdings — 5AM Venture Management, LLC

Total Portfolio Value:
$360.21M
Total Bought:
$8.75M
Total Sold:
$73.60M
Net Transaction:
-$64.86M
Notable People:
Anna Cosslett Yaeger
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Erasca, Inc.(ERAS)5,405,4043,485,971-1,919,433$20.11M$56.40M15.66%+$36.29M
Entrada Therapeutics, Inc.(TRDA)4,056,3794,056,3790$41.70M$51.19M14.21%+$9.49M
Tyra Biosciences, Inc.(TYRA)1,029,2981,029,2980$27.06M$39.42M10.94%+$12.36M
CAMP4 THERAPEUTICS CORPORATION(CAMP)5,869,0915,869,0910$35.98M$25.88M7.19%-$10.09M
Centessa Pharmaceuticals PlcADS580,945580,9450$14.53M$23.08M6.41%+$8.55M
Pharvaris N V
COM
797,600797,6000$22.13M$22.53M6.26%+$398.8K
MapLight Therapeutics, Inc.(MPLT)950,011950,0110$16.69M$19.31M5.36%+$2.63M
Tectonic Therapeutic, Inc.(TECX)606,660606,6600$12.65M$18.75M5.21%+$6.10M
Celldex Therapeutics, Inc.(CLDX)497,270497,2700$13.51M$15.77M4.38%+$2.27M
Artiva Biotherapeutics, Inc.(ARTV)2,353,3042,353,3040$10.10M$15.16M4.21%+$5.06M
EyePoint, Inc.(EYPT)1,050,0001,050,0000$19.18M$13.53M3.76%-$5.65M
Surrozen, Inc.(SRZN)387,500387,5000$8.76M$11.29M3.13%+$2.53M
Zentalis Pharmaceuticals, Inc.(ZNTL)3,947,9133,947,9130$5.33M$9.24M2.56%+$3.91M
GH Research PLC(GHRS)572,665572,6650$7.27M$8.05M2.24%+$778.8K
Protara Therapeutics, Inc.(TARA)1,369,7821,369,7820$7.30M$7.14M1.98%-$164.4K
Biohaven Ltd.(BHVN)738,972738,9720$8.34M$6.25M1.74%-$2.09M
ALX Oncology Holdings Inc.(ALXO)03,057,325+3,057,325$0$6.13M1.70%+$6.13M
Skye Bioscience, Inc.(SKYE)9,681,7639,681,7630$7.26M$5.95M1.65%-$1.31M
Rallybio Corporation(RLYB)0291,788+291,788$0$2.62M0.73%+$2.62M
Silence Therapeutics plcADS(SLN)476,200476,2000$2.90M$2.51M0.70%-$385.7K
Enliven Therapeutics Inc772,4770-772,477$11.90M$0—-$11.90M
Rallybio Corporation(RLYB)3,630,7240-3,630,724$2.49M$0—-$2.49M
Viridian Therapeutics, Inc.(VRDN)736,5950-736,595$22.92M$0—-$22.92M
Page 1 of 1
5AM Venture Management, LLC — 13F Holdings — Q1 2026 | TickerTrail